18F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy.

MLA

Wiltgen, Tun, et al. “18F-FET PET Radiomics-Based Survival Prediction in Glioblastoma Patients Receiving Radio(Chemo)Therapy.” Radiation Oncology, vol. 17, no. 1, Dec. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13014-022-02164-6.

APA

Wiltgen, T., Fleischmann, D. F., Kaiser, L., Holzgreve, A., Corradini, S., Landry, G., Ingrisch, M., Popp, I., Grosu, A. L., Unterrainer, M., Bartenstein, P., Parodi, K., Belka, C., Albert, N., Niyazi, M., & Riboldi, M. (2022). 18F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy. Radiation Oncology, 17(1), 1–11. https://doi.org/10.1186/s13014-022-02164-6

Chicago

Wiltgen, Tun, Daniel F. Fleischmann, Lena Kaiser, Adrien Holzgreve, Stefanie Corradini, Guillaume Landry, Michael Ingrisch, et al. 2022. “18F-FET PET Radiomics-Based Survival Prediction in Glioblastoma Patients Receiving Radio(Chemo)Therapy.” Radiation Oncology 17 (1): 1–11. doi:10.1186/s13014-022-02164-6.